Correlation Between GM and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both GM and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Halozyme Therapeutics, you can compare the effects of market volatilities on GM and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Halozyme Therapeutics.
Diversification Opportunities for GM and Halozyme Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between GM and Halozyme is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of GM i.e., GM and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between GM and Halozyme Therapeutics
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.59 times more return on investment than Halozyme Therapeutics. However, General Motors is 1.7 times less risky than Halozyme Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 4,863 in General Motors on August 24, 2024 and sell it today you would earn a total of 705.00 from holding General Motors or generate 14.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
General Motors vs. Halozyme Therapeutics
Performance |
| Timeline |
| General Motors |
| Halozyme Therapeutics |
GM and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and Halozyme Therapeutics
The main advantage of trading using opposite GM and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.The idea behind General Motors and Halozyme Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |